nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP1A2—Carmustine—malignant glioma	0.179	0.57	CbGbCtD
Amiodarone—CYP3A4—Temozolomide—malignant glioma	0.135	0.43	CbGbCtD
Amiodarone—Alveolitis—Temozolomide—malignant glioma	0.0237	0.0748	CcSEcCtD
Amiodarone—Pulmonary toxicity—Carmustine—malignant glioma	0.0135	0.0427	CcSEcCtD
Amiodarone—Fibrosis—Carmustine—malignant glioma	0.0108	0.0339	CcSEcCtD
Amiodarone—Pigmentation disorder—Temozolomide—malignant glioma	0.0089	0.0281	CcSEcCtD
Amiodarone—Skin necrosis—Carmustine—malignant glioma	0.0088	0.0278	CcSEcCtD
Amiodarone—Traumatic liver injury—Temozolomide—malignant glioma	0.00797	0.0252	CcSEcCtD
Amiodarone—Lucanthone—TOP2A—malignant glioma	0.00745	0.542	CrCbGaD
Amiodarone—Lung infiltration—Carmustine—malignant glioma	0.00656	0.0207	CcSEcCtD
Amiodarone—Interstitial pneumonia—Temozolomide—malignant glioma	0.00615	0.0194	CcSEcCtD
Amiodarone—Hypokinesia—Carmustine—malignant glioma	0.00455	0.0144	CcSEcCtD
Amiodarone—Interstitial lung disease—Carmustine—malignant glioma	0.00434	0.0137	CcSEcCtD
Amiodarone—Myopathy—Temozolomide—malignant glioma	0.00424	0.0134	CcSEcCtD
Amiodarone—Interstitial lung disease—Temozolomide—malignant glioma	0.0042	0.0132	CcSEcCtD
Amiodarone—Lung disorder—Temozolomide—malignant glioma	0.0042	0.0132	CcSEcCtD
Amiodarone—Scotoma—Carmustine—malignant glioma	0.00405	0.0128	CcSEcCtD
Amiodarone—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00395	0.0125	CcSEcCtD
Amiodarone—Necrosis—Carmustine—malignant glioma	0.00392	0.0124	CcSEcCtD
Amiodarone—Scotoma—Temozolomide—malignant glioma	0.00391	0.0123	CcSEcCtD
Amiodarone—THRA—brainstem—malignant glioma	0.00378	0.0564	CbGeAlD
Amiodarone—THRB—brainstem—malignant glioma	0.00378	0.0564	CbGeAlD
Amiodarone—Liver injury—Temozolomide—malignant glioma	0.00353	0.0111	CcSEcCtD
Amiodarone—Extravasation—Carmustine—malignant glioma	0.00352	0.0111	CcSEcCtD
Amiodarone—THRA—telencephalon—malignant glioma	0.00336	0.0501	CbGeAlD
Amiodarone—Oxybuprocaine—BCHE—malignant glioma	0.00334	0.243	CrCbGaD
Amiodarone—CACNA2D2—telencephalon—malignant glioma	0.00332	0.0495	CbGeAlD
Amiodarone—Drug interaction—Carmustine—malignant glioma	0.00331	0.0105	CcSEcCtD
Amiodarone—Gait disturbance—Carmustine—malignant glioma	0.00315	0.00994	CcSEcCtD
Amiodarone—Coordination abnormal—Carmustine—malignant glioma	0.00313	0.00988	CcSEcCtD
Amiodarone—Injection site reaction—Carmustine—malignant glioma	0.00306	0.00964	CcSEcCtD
Amiodarone—Gait disturbance—Temozolomide—malignant glioma	0.00304	0.00961	CcSEcCtD
Amiodarone—Coordination abnormal—Temozolomide—malignant glioma	0.00303	0.00955	CcSEcCtD
Amiodarone—Cinchocaine—BCHE—malignant glioma	0.00296	0.215	CrCbGaD
Amiodarone—Skin exfoliation—Carmustine—malignant glioma	0.00293	0.00926	CcSEcCtD
Amiodarone—Neuropathy—Carmustine—malignant glioma	0.00289	0.00911	CcSEcCtD
Amiodarone—Skin exfoliation—Temozolomide—malignant glioma	0.00284	0.00895	CcSEcCtD
Amiodarone—Neuropathy—Temozolomide—malignant glioma	0.00279	0.0088	CcSEcCtD
Amiodarone—Aplastic anaemia—Temozolomide—malignant glioma	0.00279	0.0088	CcSEcCtD
Amiodarone—Dry eye—Temozolomide—malignant glioma	0.00274	0.00866	CcSEcCtD
Amiodarone—Phlebitis—Carmustine—malignant glioma	0.00259	0.00817	CcSEcCtD
Amiodarone—Thrombophlebitis—Carmustine—malignant glioma	0.00258	0.00814	CcSEcCtD
Amiodarone—Thrombophlebitis—Temozolomide—malignant glioma	0.00249	0.00786	CcSEcCtD
Amiodarone—Hepatic failure—Temozolomide—malignant glioma	0.0024	0.00757	CcSEcCtD
Amiodarone—CACNA2D2—midbrain—malignant glioma	0.00238	0.0356	CbGeAlD
Amiodarone—THRA—spinal cord—malignant glioma	0.00235	0.0351	CbGeAlD
Amiodarone—CACNA2D2—spinal cord—malignant glioma	0.00233	0.0347	CbGeAlD
Amiodarone—Hot flush—Temozolomide—malignant glioma	0.00231	0.00728	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00229	0.00721	CcSEcCtD
Amiodarone—Menopausal symptoms—Temozolomide—malignant glioma	0.00229	0.00721	CcSEcCtD
Amiodarone—Ataxia—Carmustine—malignant glioma	0.0021	0.00662	CcSEcCtD
Amiodarone—Liver function test abnormal—Carmustine—malignant glioma	0.00206	0.0065	CcSEcCtD
Amiodarone—Ataxia—Temozolomide—malignant glioma	0.00203	0.0064	CcSEcCtD
Amiodarone—Muscular weakness—Carmustine—malignant glioma	0.00197	0.00621	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00194	0.00613	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00194	0.00613	CcSEcCtD
Amiodarone—THRB—central nervous system—malignant glioma	0.00191	0.0285	CbGeAlD
Amiodarone—THRA—central nervous system—malignant glioma	0.00191	0.0285	CbGeAlD
Amiodarone—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.0019	0.006	CcSEcCtD
Amiodarone—Muscular weakness—Temozolomide—malignant glioma	0.0019	0.006	CcSEcCtD
Amiodarone—CACNA2D2—central nervous system—malignant glioma	0.00189	0.0282	CbGeAlD
Amiodarone—THRB—cerebellum—malignant glioma	0.00186	0.0278	CbGeAlD
Amiodarone—THRA—cerebellum—malignant glioma	0.00186	0.0278	CbGeAlD
Amiodarone—CACNA2D2—cerebellum—malignant glioma	0.00185	0.0275	CbGeAlD
Amiodarone—Pancytopenia—Carmustine—malignant glioma	0.00183	0.00578	CcSEcCtD
Amiodarone—Neutropenia—Carmustine—malignant glioma	0.0018	0.00569	CcSEcCtD
Amiodarone—Pancytopenia—Temozolomide—malignant glioma	0.00177	0.00559	CcSEcCtD
Amiodarone—Neutropenia—Temozolomide—malignant glioma	0.00174	0.0055	CcSEcCtD
Amiodarone—Pneumonia—Carmustine—malignant glioma	0.00173	0.00546	CcSEcCtD
Amiodarone—Erectile dysfunction—Temozolomide—malignant glioma	0.00172	0.00542	CcSEcCtD
Amiodarone—Photosensitivity reaction—Temozolomide—malignant glioma	0.0017	0.00537	CcSEcCtD
Amiodarone—Weight increased—Temozolomide—malignant glioma	0.0017	0.00535	CcSEcCtD
Amiodarone—Renal failure—Carmustine—malignant glioma	0.00169	0.00533	CcSEcCtD
Amiodarone—Weight decreased—Temozolomide—malignant glioma	0.00169	0.00532	CcSEcCtD
Amiodarone—Neuropathy peripheral—Carmustine—malignant glioma	0.00169	0.00532	CcSEcCtD
Amiodarone—Pneumonia—Temozolomide—malignant glioma	0.00167	0.00528	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00165	0.0052	CcSEcCtD
Amiodarone—Neuropathy peripheral—Temozolomide—malignant glioma	0.00163	0.00514	CcSEcCtD
Amiodarone—ADRB1—telencephalon—malignant glioma	0.0016	0.0239	CbGeAlD
Amiodarone—SIGMAR1—telencephalon—malignant glioma	0.00154	0.0229	CbGeAlD
Amiodarone—Hallucination—Carmustine—malignant glioma	0.00154	0.00485	CcSEcCtD
Amiodarone—THRA—brain—malignant glioma	0.00151	0.0226	CbGeAlD
Amiodarone—THRB—brain—malignant glioma	0.00151	0.0226	CbGeAlD
Amiodarone—CACNA2D2—brain—malignant glioma	0.0015	0.0224	CbGeAlD
Amiodarone—CACNA1H—cerebellum—malignant glioma	0.0015	0.0223	CbGeAlD
Amiodarone—Hepatitis—Temozolomide—malignant glioma	0.00149	0.00471	CcSEcCtD
Amiodarone—Visual impairment—Carmustine—malignant glioma	0.00149	0.0047	CcSEcCtD
Amiodarone—Hallucination—Temozolomide—malignant glioma	0.00148	0.00468	CcSEcCtD
Amiodarone—Visual impairment—Temozolomide—malignant glioma	0.00144	0.00454	CcSEcCtD
Amiodarone—Flushing—Carmustine—malignant glioma	0.00143	0.00452	CcSEcCtD
Amiodarone—Erythema multiforme—Temozolomide—malignant glioma	0.00141	0.00445	CcSEcCtD
Amiodarone—Tinnitus—Temozolomide—malignant glioma	0.00139	0.00439	CcSEcCtD
Amiodarone—Flushing—Temozolomide—malignant glioma	0.00138	0.00437	CcSEcCtD
Amiodarone—Arrhythmia—Carmustine—malignant glioma	0.00138	0.00435	CcSEcCtD
Amiodarone—Alopecia—Carmustine—malignant glioma	0.00136	0.00431	CcSEcCtD
Amiodarone—Erythema—Carmustine—malignant glioma	0.00134	0.00424	CcSEcCtD
Amiodarone—Alopecia—Temozolomide—malignant glioma	0.00132	0.00416	CcSEcCtD
Amiodarone—Back pain—Carmustine—malignant glioma	0.0013	0.0041	CcSEcCtD
Amiodarone—Erythema—Temozolomide—malignant glioma	0.0013	0.0041	CcSEcCtD
Amiodarone—Dysgeusia—Temozolomide—malignant glioma	0.00127	0.00401	CcSEcCtD
Amiodarone—Vision blurred—Carmustine—malignant glioma	0.00127	0.004	CcSEcCtD
Amiodarone—Tremor—Carmustine—malignant glioma	0.00126	0.00397	CcSEcCtD
Amiodarone—Back pain—Temozolomide—malignant glioma	0.00126	0.00396	CcSEcCtD
Amiodarone—Agitation—Carmustine—malignant glioma	0.00123	0.0039	CcSEcCtD
Amiodarone—Vision blurred—Temozolomide—malignant glioma	0.00122	0.00386	CcSEcCtD
Amiodarone—KCNH2—telencephalon—malignant glioma	0.00122	0.0182	CbGeAlD
Amiodarone—Tremor—Temozolomide—malignant glioma	0.00122	0.00384	CcSEcCtD
Amiodarone—CACNA1H—brain—malignant glioma	0.00122	0.0181	CbGeAlD
Amiodarone—SIGMAR1—medulla oblongata—malignant glioma	0.00121	0.018	CbGeAlD
Amiodarone—Ill-defined disorder—Temozolomide—malignant glioma	0.0012	0.0038	CcSEcCtD
Amiodarone—Agitation—Temozolomide—malignant glioma	0.00119	0.00377	CcSEcCtD
Amiodarone—Angioedema—Temozolomide—malignant glioma	0.00119	0.00375	CcSEcCtD
Amiodarone—Malaise—Temozolomide—malignant glioma	0.00117	0.0037	CcSEcCtD
Amiodarone—Vertigo—Temozolomide—malignant glioma	0.00117	0.00368	CcSEcCtD
Amiodarone—Anxiety—Carmustine—malignant glioma	0.00114	0.0036	CcSEcCtD
Amiodarone—Cough—Temozolomide—malignant glioma	0.00113	0.00358	CcSEcCtD
Amiodarone—CYP2A6—cerebellum—malignant glioma	0.00111	0.0165	CbGeAlD
Amiodarone—Confusional state—Carmustine—malignant glioma	0.00111	0.00349	CcSEcCtD
Amiodarone—ABCB1—blood vessel—malignant glioma	0.00111	0.0165	CbGeAlD
Amiodarone—SIGMAR1—midbrain—malignant glioma	0.0011	0.0165	CbGeAlD
Amiodarone—Anxiety—Temozolomide—malignant glioma	0.0011	0.00348	CcSEcCtD
Amiodarone—Oedema—Carmustine—malignant glioma	0.0011	0.00346	CcSEcCtD
Amiodarone—Discomfort—Temozolomide—malignant glioma	0.00109	0.00345	CcSEcCtD
Amiodarone—Infection—Carmustine—malignant glioma	0.00109	0.00344	CcSEcCtD
Amiodarone—Dry mouth—Temozolomide—malignant glioma	0.00108	0.00341	CcSEcCtD
Amiodarone—SIGMAR1—spinal cord—malignant glioma	0.00108	0.0161	CbGeAlD
Amiodarone—Thrombocytopenia—Carmustine—malignant glioma	0.00107	0.00339	CcSEcCtD
Amiodarone—Tachycardia—Carmustine—malignant glioma	0.00107	0.00338	CcSEcCtD
Amiodarone—Confusional state—Temozolomide—malignant glioma	0.00107	0.00337	CcSEcCtD
Amiodarone—Anaphylactic shock—Temozolomide—malignant glioma	0.00106	0.00334	CcSEcCtD
Amiodarone—Oedema—Temozolomide—malignant glioma	0.00106	0.00334	CcSEcCtD
Amiodarone—Infection—Temozolomide—malignant glioma	0.00105	0.00332	CcSEcCtD
Amiodarone—Anorexia—Carmustine—malignant glioma	0.00105	0.0033	CcSEcCtD
Amiodarone—Thrombocytopenia—Temozolomide—malignant glioma	0.00104	0.00328	CcSEcCtD
Amiodarone—Skin disorder—Temozolomide—malignant glioma	0.00103	0.00325	CcSEcCtD
Amiodarone—Hypotension—Carmustine—malignant glioma	0.00102	0.00323	CcSEcCtD
Amiodarone—Hyperhidrosis—Temozolomide—malignant glioma	0.00102	0.00323	CcSEcCtD
Amiodarone—Anorexia—Temozolomide—malignant glioma	0.00101	0.00319	CcSEcCtD
Amiodarone—Insomnia—Carmustine—malignant glioma	0.000992	0.00313	CcSEcCtD
Amiodarone—Paraesthesia—Carmustine—malignant glioma	0.000985	0.00311	CcSEcCtD
Amiodarone—Dyspnoea—Carmustine—malignant glioma	0.000978	0.00309	CcSEcCtD
Amiodarone—KCNH2—medulla oblongata—malignant glioma	0.000961	0.0143	CbGeAlD
Amiodarone—Insomnia—Temozolomide—malignant glioma	0.000959	0.00303	CcSEcCtD
Amiodarone—Decreased appetite—Carmustine—malignant glioma	0.000953	0.00301	CcSEcCtD
Amiodarone—Paraesthesia—Temozolomide—malignant glioma	0.000952	0.003	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Carmustine—malignant glioma	0.000947	0.00299	CcSEcCtD
Amiodarone—Dyspnoea—Temozolomide—malignant glioma	0.000945	0.00298	CcSEcCtD
Amiodarone—Pain—Carmustine—malignant glioma	0.000938	0.00296	CcSEcCtD
Amiodarone—Constipation—Carmustine—malignant glioma	0.000938	0.00296	CcSEcCtD
Amiodarone—Dyspepsia—Temozolomide—malignant glioma	0.000933	0.00294	CcSEcCtD
Amiodarone—Decreased appetite—Temozolomide—malignant glioma	0.000921	0.00291	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000915	0.00289	CcSEcCtD
Amiodarone—Fatigue—Temozolomide—malignant glioma	0.000914	0.00288	CcSEcCtD
Amiodarone—ADRB1—central nervous system—malignant glioma	0.00091	0.0136	CbGeAlD
Amiodarone—Pain—Temozolomide—malignant glioma	0.000906	0.00286	CcSEcCtD
Amiodarone—Constipation—Temozolomide—malignant glioma	0.000906	0.00286	CcSEcCtD
Amiodarone—Feeling abnormal—Carmustine—malignant glioma	0.000904	0.00285	CcSEcCtD
Amiodarone—CYP2A6—brain—malignant glioma	0.000899	0.0134	CbGeAlD
Amiodarone—Gastrointestinal pain—Carmustine—malignant glioma	0.000897	0.00283	CcSEcCtD
Amiodarone—KCNH2—midbrain—malignant glioma	0.000878	0.0131	CbGeAlD
Amiodarone—Feeling abnormal—Temozolomide—malignant glioma	0.000873	0.00276	CcSEcCtD
Amiodarone—Body temperature increased—Carmustine—malignant glioma	0.000867	0.00274	CcSEcCtD
Amiodarone—Abdominal pain—Carmustine—malignant glioma	0.000867	0.00274	CcSEcCtD
Amiodarone—Gastrointestinal pain—Temozolomide—malignant glioma	0.000867	0.00274	CcSEcCtD
Amiodarone—KCNH2—spinal cord—malignant glioma	0.000857	0.0128	CbGeAlD
Amiodarone—SIGMAR1—cerebellum—malignant glioma	0.000854	0.0127	CbGeAlD
Amiodarone—Urticaria—Temozolomide—malignant glioma	0.000842	0.00266	CcSEcCtD
Amiodarone—CYP2D6—brainstem—malignant glioma	0.00084	0.0125	CbGeAlD
Amiodarone—Body temperature increased—Temozolomide—malignant glioma	0.000838	0.00264	CcSEcCtD
Amiodarone—Abdominal pain—Temozolomide—malignant glioma	0.000838	0.00264	CcSEcCtD
Amiodarone—Hypersensitivity—Carmustine—malignant glioma	0.000808	0.00255	CcSEcCtD
Amiodarone—Asthenia—Carmustine—malignant glioma	0.000787	0.00248	CcSEcCtD
Amiodarone—Hypersensitivity—Temozolomide—malignant glioma	0.000781	0.00246	CcSEcCtD
Amiodarone—Asthenia—Temozolomide—malignant glioma	0.00076	0.0024	CcSEcCtD
Amiodarone—Diarrhoea—Carmustine—malignant glioma	0.00075	0.00237	CcSEcCtD
Amiodarone—Pruritus—Temozolomide—malignant glioma	0.00075	0.00237	CcSEcCtD
Amiodarone—CYP2D6—telencephalon—malignant glioma	0.000746	0.0111	CbGeAlD
Amiodarone—Dizziness—Carmustine—malignant glioma	0.000725	0.00229	CcSEcCtD
Amiodarone—Diarrhoea—Temozolomide—malignant glioma	0.000725	0.00229	CcSEcCtD
Amiodarone—ADRB1—brain—malignant glioma	0.000723	0.0108	CbGeAlD
Amiodarone—Dizziness—Temozolomide—malignant glioma	0.000701	0.00221	CcSEcCtD
Amiodarone—Vomiting—Carmustine—malignant glioma	0.000697	0.0022	CcSEcCtD
Amiodarone—KCNH2—central nervous system—malignant glioma	0.000695	0.0104	CbGeAlD
Amiodarone—SIGMAR1—brain—malignant glioma	0.000693	0.0103	CbGeAlD
Amiodarone—Rash—Carmustine—malignant glioma	0.000692	0.00218	CcSEcCtD
Amiodarone—Dermatitis—Carmustine—malignant glioma	0.000691	0.00218	CcSEcCtD
Amiodarone—Headache—Carmustine—malignant glioma	0.000687	0.00217	CcSEcCtD
Amiodarone—KCNH2—cerebellum—malignant glioma	0.000679	0.0101	CbGeAlD
Amiodarone—Vomiting—Temozolomide—malignant glioma	0.000674	0.00213	CcSEcCtD
Amiodarone—Rash—Temozolomide—malignant glioma	0.000668	0.00211	CcSEcCtD
Amiodarone—Dermatitis—Temozolomide—malignant glioma	0.000668	0.00211	CcSEcCtD
Amiodarone—Headache—Temozolomide—malignant glioma	0.000664	0.0021	CcSEcCtD
Amiodarone—ABCB1—embryo—malignant glioma	0.00066	0.00984	CbGeAlD
Amiodarone—Nausea—Carmustine—malignant glioma	0.000651	0.00206	CcSEcCtD
Amiodarone—Nausea—Temozolomide—malignant glioma	0.00063	0.00199	CcSEcCtD
Amiodarone—CYP1A1—central nervous system—malignant glioma	0.000587	0.00876	CbGeAlD
Amiodarone—ABCB1—retina—malignant glioma	0.000583	0.0087	CbGeAlD
Amiodarone—KCNH2—brain—malignant glioma	0.000552	0.00823	CbGeAlD
Amiodarone—ABCB1—telencephalon—malignant glioma	0.000536	0.008	CbGeAlD
Amiodarone—CYP2C8—brain—malignant glioma	0.000505	0.00753	CbGeAlD
Amiodarone—CYP1A1—brain—malignant glioma	0.000466	0.00695	CbGeAlD
Amiodarone—CYP3A4—central nervous system—malignant glioma	0.000431	0.00643	CbGeAlD
Amiodarone—CYP2D6—central nervous system—malignant glioma	0.000424	0.00632	CbGeAlD
Amiodarone—ABCB1—medulla oblongata—malignant glioma	0.000421	0.00629	CbGeAlD
Amiodarone—CYP2D6—cerebellum—malignant glioma	0.000414	0.00618	CbGeAlD
Amiodarone—ABCB1—midbrain—malignant glioma	0.000385	0.00575	CbGeAlD
Amiodarone—ABCB1—spinal cord—malignant glioma	0.000376	0.00561	CbGeAlD
Amiodarone—CYP2D6—brain—malignant glioma	0.000337	0.00502	CbGeAlD
Amiodarone—ABCB1—central nervous system—malignant glioma	0.000305	0.00455	CbGeAlD
Amiodarone—ABCB1—cerebellum—malignant glioma	0.000298	0.00445	CbGeAlD
Amiodarone—ABCB1—brain—malignant glioma	0.000242	0.00361	CbGeAlD
Amiodarone—ADRB1—Signaling Pathways—CDKN2B—malignant glioma	2.81e-05	9.72e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SLC5A5—malignant glioma	2.8e-05	9.69e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS1—malignant glioma	2.8e-05	9.68e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.79e-05	9.64e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NCOR1—malignant glioma	2.78e-05	9.63e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.73e-05	9.45e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTK2—malignant glioma	2.73e-05	9.44e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL8—malignant glioma	2.71e-05	9.4e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—IDH1—malignant glioma	2.71e-05	9.37e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HES1—malignant glioma	2.68e-05	9.27e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTT1—malignant glioma	2.66e-05	9.22e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NCOR1—malignant glioma	2.66e-05	9.22e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.65e-05	9.17e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—RAF1—malignant glioma	2.63e-05	9.09e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.62e-05	9.08e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SPHK1—malignant glioma	2.62e-05	9.07e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTT1—malignant glioma	2.6e-05	9e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—BCHE—malignant glioma	2.6e-05	9e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—IL2—malignant glioma	2.59e-05	8.98e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.58e-05	8.93e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SLC5A5—malignant glioma	2.57e-05	8.89e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP2C18—malignant glioma	2.57e-05	8.88e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CB—malignant glioma	2.56e-05	8.88e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PDGFRA—malignant glioma	2.55e-05	8.83e-05	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.52e-05	8.73e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS1—malignant glioma	2.5e-05	8.64e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.49e-05	8.62e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.49e-05	8.61e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SPP1—malignant glioma	2.48e-05	8.57e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CAV1—malignant glioma	2.47e-05	8.56e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL8—malignant glioma	2.46e-05	8.53e-05	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—AKT1—malignant glioma	2.46e-05	8.52e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTT1—malignant glioma	2.45e-05	8.48e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS1—malignant glioma	2.44e-05	8.43e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—IDH2—malignant glioma	2.43e-05	8.41e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTT1—malignant glioma	2.43e-05	8.41e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.43e-05	8.4e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.42e-05	8.37e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.41e-05	8.33e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTP1—malignant glioma	2.39e-05	8.26e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL2—malignant glioma	2.36e-05	8.15e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TERT—malignant glioma	2.35e-05	8.12e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CAT—malignant glioma	2.32e-05	8.04e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—BCHE—malignant glioma	2.32e-05	8.03e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS1—malignant glioma	2.3e-05	7.94e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.29e-05	7.93e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PDGFB—malignant glioma	2.29e-05	7.93e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.29e-05	7.92e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.28e-05	7.91e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGFR1—malignant glioma	2.28e-05	7.89e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS1—malignant glioma	2.28e-05	7.88e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CAV1—malignant glioma	2.27e-05	7.85e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.27e-05	7.85e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—BCHE—malignant glioma	2.26e-05	7.84e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTP1—malignant glioma	2.26e-05	7.81e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CG—malignant glioma	2.25e-05	7.8e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HIF1A—malignant glioma	2.24e-05	7.77e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SLC5A5—malignant glioma	2.24e-05	7.74e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.2e-05	7.63e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CAT—malignant glioma	2.19e-05	7.6e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NCOR1—malignant glioma	2.19e-05	7.59e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PPARG—malignant glioma	2.18e-05	7.53e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CAV1—malignant glioma	2.17e-05	7.51e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.17e-05	7.5e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.15e-05	7.43e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KDR—malignant glioma	2.15e-05	7.43e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—BCHE—malignant glioma	2.13e-05	7.39e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.13e-05	7.36e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—BCHE—malignant glioma	2.12e-05	7.32e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.11e-05	7.3e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.1e-05	7.26e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.09e-05	7.23e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—IDH1—malignant glioma	2.09e-05	7.23e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTT1—malignant glioma	2.07e-05	7.18e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NCOR1—malignant glioma	2.07e-05	7.18e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTP1—malignant glioma	2.07e-05	7.16e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FN1—malignant glioma	2.07e-05	7.15e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—F2—malignant glioma	2.07e-05	7.15e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CG—malignant glioma	2.07e-05	7.15e-05	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.06e-05	7.13e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—BAD—malignant glioma	2.04e-05	7.07e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	2.02e-05	7e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SPHK1—malignant glioma	2.02e-05	7e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CAT—malignant glioma	2.01e-05	6.97e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PPARG—malignant glioma	1.99e-05	6.9e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CD—malignant glioma	1.98e-05	6.86e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CD80—malignant glioma	1.98e-05	6.86e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.98e-05	6.85e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APC—malignant glioma	1.98e-05	6.84e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	1.98e-05	6.84e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.98e-05	6.84e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.96e-05	6.78e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGF—malignant glioma	1.95e-05	6.77e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS1—malignant glioma	1.94e-05	6.73e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTPN11—malignant glioma	1.94e-05	6.72e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.94e-05	6.71e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NCOR1—malignant glioma	1.9e-05	6.58e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.87e-05	6.48e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—BRAF—malignant glioma	1.86e-05	6.43e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTP1—malignant glioma	1.85e-05	6.39e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CD—malignant glioma	1.82e-05	6.29e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT2—malignant glioma	1.81e-05	6.26e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—BCHE—malignant glioma	1.81e-05	6.26e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTP1—malignant glioma	1.8e-05	6.24e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—malignant glioma	1.8e-05	6.24e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CAT—malignant glioma	1.8e-05	6.22e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CAV1—malignant glioma	1.79e-05	6.19e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.79e-05	6.18e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CAT—malignant glioma	1.75e-05	6.07e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	1.74e-05	6.02e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CB—malignant glioma	1.73e-05	5.98e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	1.72e-05	5.96e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—malignant glioma	1.71e-05	5.92e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.71e-05	5.91e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—malignant glioma	1.7e-05	5.89e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—malignant glioma	1.7e-05	5.88e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NCOR1—malignant glioma	1.7e-05	5.87e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CAV1—malignant glioma	1.69e-05	5.85e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.69e-05	5.84e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—malignant glioma	1.68e-05	5.83e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.67e-05	5.79e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGF2—malignant glioma	1.66e-05	5.76e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NCOR1—malignant glioma	1.66e-05	5.73e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CAT—malignant glioma	1.65e-05	5.72e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CAT—malignant glioma	1.64e-05	5.67e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.63e-05	5.64e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.61e-05	5.59e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTT1—malignant glioma	1.6e-05	5.54e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CB—malignant glioma	1.58e-05	5.48e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPARG—malignant glioma	1.57e-05	5.44e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—malignant glioma	1.57e-05	5.43e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	1.56e-05	5.41e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NCOR1—malignant glioma	1.56e-05	5.4e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MDM2—malignant glioma	1.56e-05	5.39e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RAF1—malignant glioma	1.55e-05	5.37e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CAV1—malignant glioma	1.55e-05	5.36e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NCOR1—malignant glioma	1.55e-05	5.35e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CG—malignant glioma	1.54e-05	5.33e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—malignant glioma	1.54e-05	5.31e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	1.52e-05	5.24e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS1—malignant glioma	1.5e-05	5.19e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—malignant glioma	1.49e-05	5.17e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPARG—malignant glioma	1.49e-05	5.14e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.48e-05	5.12e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.46e-05	5.05e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—malignant glioma	1.46e-05	5.04e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—malignant glioma	1.44e-05	4.98e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.43e-05	4.96e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.41e-05	4.88e-05	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	1.41e-05	4.87e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CAT—malignant glioma	1.4e-05	4.84e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—BCHE—malignant glioma	1.4e-05	4.83e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CASP3—malignant glioma	1.39e-05	4.82e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—malignant glioma	1.39e-05	4.82e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CAV1—malignant glioma	1.38e-05	4.79e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.38e-05	4.77e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—malignant glioma	1.37e-05	4.73e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARG—malignant glioma	1.36e-05	4.71e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.35e-05	4.68e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CAV1—malignant glioma	1.35e-05	4.67e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NCOR1—malignant glioma	1.32e-05	4.58e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.32e-05	4.57e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—malignant glioma	1.32e-05	4.56e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—malignant glioma	1.31e-05	4.53e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—AKT1—malignant glioma	1.28e-05	4.42e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CAV1—malignant glioma	1.27e-05	4.4e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CAV1—malignant glioma	1.26e-05	4.36e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.26e-05	4.36e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.25e-05	4.32e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.24e-05	4.29e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—malignant glioma	1.24e-05	4.28e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CG—malignant glioma	1.23e-05	4.26e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARG—malignant glioma	1.22e-05	4.21e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.2e-05	4.17e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARG—malignant glioma	1.19e-05	4.11e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—VEGFA—malignant glioma	1.18e-05	4.09e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.18e-05	4.08e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—malignant glioma	1.17e-05	4.05e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—malignant glioma	1.17e-05	4.05e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.16e-05	4.01e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.15e-05	3.98e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARG—malignant glioma	1.12e-05	3.87e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—malignant glioma	1.11e-05	3.84e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARG—malignant glioma	1.11e-05	3.84e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.11e-05	3.83e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—malignant glioma	1.09e-05	3.77e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.08e-05	3.74e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CD—malignant glioma	1.08e-05	3.74e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CAT—malignant glioma	1.08e-05	3.74e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—malignant glioma	1.08e-05	3.73e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CAV1—malignant glioma	1.08e-05	3.73e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—malignant glioma	1.07e-05	3.71e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—malignant glioma	1.06e-05	3.68e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.05e-05	3.64e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.03e-05	3.56e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOR1—malignant glioma	1.02e-05	3.53e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—malignant glioma	1.02e-05	3.53e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.02e-05	3.53e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.01e-05	3.49e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—malignant glioma	1.01e-05	3.48e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CG—malignant glioma	9.81e-06	3.4e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CB—malignant glioma	9.65e-06	3.34e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PIK3CA—malignant glioma	9.65e-06	3.34e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—malignant glioma	9.56e-06	3.31e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARG—malignant glioma	9.47e-06	3.28e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CB—malignant glioma	9.42e-06	3.26e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—malignant glioma	9.34e-06	3.23e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—malignant glioma	9.33e-06	3.23e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	9.24e-06	3.2e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—malignant glioma	8.94e-06	3.09e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CB—malignant glioma	8.88e-06	3.07e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CB—malignant glioma	8.8e-06	3.05e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—malignant glioma	8.8e-06	3.04e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—malignant glioma	8.72e-06	3.02e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CD—malignant glioma	8.63e-06	2.99e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—AKT1—malignant glioma	8.6e-06	2.98e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—malignant glioma	8.34e-06	2.89e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CAV1—malignant glioma	8.32e-06	2.88e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—malignant glioma	8.14e-06	2.82e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—AKT1—malignant glioma	7.88e-06	2.73e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—malignant glioma	7.67e-06	2.66e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PIK3CA—malignant glioma	7.61e-06	2.63e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—malignant glioma	7.6e-06	2.63e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CG—malignant glioma	7.57e-06	2.62e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—AKT1—malignant glioma	7.55e-06	2.61e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CB—malignant glioma	7.52e-06	2.6e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—malignant glioma	7.45e-06	2.58e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARG—malignant glioma	7.31e-06	2.53e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PIK3CA—malignant glioma	7.19e-06	2.49e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CD—malignant glioma	6.66e-06	2.3e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PIK3CA—malignant glioma	6.59e-06	2.28e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—malignant glioma	6.5e-06	2.25e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—AKT1—malignant glioma	6.22e-06	2.15e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PIK3CA—malignant glioma	5.88e-06	2.04e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—AKT1—malignant glioma	5.87e-06	2.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.8e-06	2.01e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—malignant glioma	5.75e-06	1.99e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PIK3CA—malignant glioma	5.74e-06	1.99e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PIK3CA—malignant glioma	5.41e-06	1.87e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—AKT1—malignant glioma	5.38e-06	1.86e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PIK3CA—malignant glioma	5.36e-06	1.86e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—malignant glioma	5.02e-06	1.74e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—AKT1—malignant glioma	4.81e-06	1.66e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—AKT1—malignant glioma	4.69e-06	1.62e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PIK3CA—malignant glioma	4.58e-06	1.59e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—AKT1—malignant glioma	4.42e-06	1.53e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—AKT1—malignant glioma	4.38e-06	1.52e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—AKT1—malignant glioma	3.74e-06	1.3e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.54e-06	1.22e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—AKT1—malignant glioma	2.89e-06	1e-05	CbGpPWpGaD
